🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCompounding & FormulationFDA warning letters to compounding pharmacies — November 2025 Page 4

FDA warning letters to compounding pharmacies — November 2025

gary_naperville Thu, Dec 18, 2025 at 7:46 PM 36 replies 1,552 viewsPage 4 of 8
tammy_FL
Member
234
890
Nov 2024
Tampa, FL
Dec 19, 2025 at 1:26 AM#16

Congrats VanRx_Mike!! You should be so proud of yourself. 🎉

11 24Dr.LipidDallas, alex_tucson, kevin_tulsa and 8 others
Reply Quote Save Share Report
pam_stl
Member
267
1,123
Oct 2024
St. Louis, MO
Dec 19, 2025 at 1:43 AM#17

gary_naperville's experience with FDA warning letters to resonates deeply with mine. I went through almost the identical process — starting dose, titration timeline, side effects, everything.

The main difference: I am on a different medication. But the overall trajectory has been remarkably similar. Down 47 lbs in 12 months.

One thing I would add that gary_naperville did not mention: my sleep quality improved dramatically.

29 15HealthEcon_DC, PedsEndoPhilly, SleepDoc_PDX and 26 others
Reply Quote Save Share Report
pam_columbus
Member
312
1,345
Aug 2024
Columbus, OH
Dec 19, 2025 at 2:00 AM#18

Bookmarked 📌 The FDA warning letters info in this thread is essential. Coming back to this for sure.

2 1Dr.LipidDallas, alex_tucson
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
PedsEndoPhilly
Member
345
1,890
Jun 2024
Philadelphia, PA
Dec 19, 2025 at 2:17 AM#19

Clinical perspective on FDA warning letters to compounding:

I have managed over 200 patients on GLP-1 therapy and this topic comes up frequently. What the data shows — and what I see in practice — is that proper titration prevents most adverse events.

For this specific question, I would recommend: reviewing the relevant clinical guidelines.

Last edited: Dec 19, 2025 at 7:17 AM
49 21Dr.LeslieOBGYN, MikeNYC_runner and 46 others
Reply Quote Save Share Report
AussieAnna
Member
678
2,890
Jun 2024
Sydney, AU
Dec 19, 2025 at 2:34 AM#20

Subscribing to this thread. FDA warning letters to is exactly what I've been researching. 🙏

31 16pete_manc_UK, anna.melb_AU, mark_tokyo and 28 others
Reply Quote Save Share Report

Similar Threads

503A vs 503B compounding — regulatory framework explained4 replies
Compounded semaglutide stability: accelerated degradation study results6 replies
Lyophilized vs liquid peptides — stability and bioavailability comparison18 replies
Bacteriostatic water sourcing and sterility considerations8 replies
State-by-state compounding pharmacy regulations — 2026 map8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register